(June 3, 2016, 9:29 AM EDT) -- WASHINGTON, D.C. — In a brief filed May 20, Ariosa Diagnostics Inc. argues to the U.S. Supreme Court that it should deny Sequenom Inc.’s petition for a review of its fetal DNA test patent because an appellate court correctly applied Mayo Collaborative Services v. Prometheus Laboratories Inc. (566 U.S. __ 132 S. Ct. 1289 [2012]) to affirm the patent’s invalidation (Sequenom Inc. v. Ariosa Diagnostics Inc., et al., No. 15-1182, U.S. Sup.)....